Sep 14, 2018· Comment from Association for Accessible Medicines (AAM)· FDA-2018-N-2065-0004
The Association for Accessible Medicines (AAM) is pleased to provide comments to the Food and Drug Administrations (FDAs or the Agencys) proposed list, entitled Alternative or Streamlined Mechanisms for Complying with the Current Good Manufacturing Practice Requirements for Combination Products